Airway Medix S.A. Logo

Airway Medix S.A.

ISIN: PLAIRWY00017 | Ticker: AWM | LEI: 259400MDMODKWHZ2EU17
Sector: Health CareSub-Industry: Health Care Equipment
Country: Poland

About Airway Medix S.A.

Company Description

Airway Medix S.A. focuses on research and development work and commercialisation of innovative, disposable devices for the mechanically ventilated patients in the Intensive Care Units (ICU), and for the patients in life-threatening conditions in the anaesthesiology departments.

The family of products developed by Airway Medix is aimed at limiting the growth of a biofilm in patients, reducing the microbial flora in the oral cavity and improving the fitting and tightness of intubation tubes. By reducing biofilm formation and preventing entry of infected material into the lungs, the products protect patients from acquiring Ventilation Associated Pneumonia (VAP).

Ventilation Associated Pneumonia is considered one of the most serious and most costly hospital-acquired infections.

Year founded

2013

Served area

Worldwide

Headquarters

Gen. Zajączka 11/14, 01-510 Warszawa – Poland

Financial statements

Download as Excel
Line item in (pln) 02.01.2020 01.01.2021 01.01.2022
Assets N/A 51,483,000.00 44,496,000.00
Noncurrent Assets N/A 29,048,000.00 38,582,000.00
Property Plant And Equipment N/A 2,374,000.00 89,000.00
Intangible Assets Other Than Goodwill N/A 25,299,000.00 37,706,000.00
Deferred Tax Assets N/A 1,375,000.00 787,000.00
Current Assets N/A 22,435,000.00 5,914,000.00
Inventories N/A 220,000.00 332,000.00
Trade And Other Current Receivables N/A 780,000.00 510,000.00
Current Tax Assets Current N/A 0.00 0.00
Other Current Financial Assets N/A 4,683,000.00 5,043,000.00
Cash and cash equivalents 707,000.00 2,215,000.00 29,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 22,435,000.00 5,914,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 0.00 0.00
Equity And Liabilities N/A 51,483,000.00 44,496,000.00
Equity 32,830,000.00 30,653,000.00 23,901,000.00
Issued Capital N/A 19,862,000.00 19,862,000.00
Retained Earnings N/A 6,026,000.00 -1,103,000.00
Share Premium N/A 1,174,000.00 1,174,000.00
Reserve Of Sharebased Payments N/A 1,147,000.00 1,147,000.00
Capital Reserve N/A 1,952,000.00 1,952,000.00
Equity Attributable To Owners Of Parent N/A 30,653,000.00 23,901,000.00
Noncontrolling Interests N/A 0.00 0.00
Liabilities N/A 20,830,000.00 20,595,000.00
Noncurrent Liabilities N/A 7,865,000.00 2,266,000.00
Noncurrent Provisions For Employee Benefits N/A 349,000.00 321,000.00
Noncurrent Government Grants N/A 1,497,000.00 1,457,000.00
Deferred Tax Liabilities N/A 3,271,000.00 357,000.00
Longterm Borrowings N/A 117,000.00 131,000.00
Current Liabilities N/A 12,965,000.00 18,329,000.00
Current Provisions For Employee Benefits N/A 367,000.00 1,154,000.00
Other Shortterm Provisions N/A 54,000.00 67,000.00
Trade And Other Current Payables N/A 2,100,000.00 3,793,000.00
Current Tax Liabilities Current N/A 30,000.00 87,000.00
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale N/A 12,965,000.00 18,329,000.00
Liabilities Included In Disposal Groups Classified As Held For Sale N/A 0.00 0.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 10,293,000.00 13,228,000.00
Line item in (pln) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
Revenue 257,000.00 6,000.00
Other Income 92,000.00 20,060,000.00
Raw Materials And Consumables Used 0.00 0.00
Services Expense 1,907,000.00 1,444,000.00
Wages And Salaries 225,000.00 310,000.00
Social Security Contributions 4,000.00 5,000.00
Depreciation And Amortisation Expense 0.00 0.00
Tax Expense Other Than Income Tax Expense 70,000.00 13,000.00
Other Expense By Nature 0.00 0.00
Finance Income 995,000.00 406,000.00
Finance Costs 767,000.00 1,513,000.00
Profit Loss Before Tax -1,986,000.00 -9,369,000.00
Income Tax Expense Continuing Operations 388,000.00 -2,325,000.00
Profit Loss From Continuing Operations -2,374,000.00 -7,044,000.00
Profit Loss From Discontinued Operations 0.00 0.00
Profit (loss) -2,374,000.00 -7,044,000.00
Profit Loss Attributable To Owners Of Parent -2,374,000.00 -7,044,000.00
Profit Loss Attributable To Noncontrolling Interests 0.00 0.00
Line item in (pln) 01.01.2021 02.01.2020 01.01.2022
Profit (loss) -2,374,000.00 N/A -7,044,000.00
Adjustments For Decrease Increase In Inventories -29,000.00 N/A -112,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 19,000.00 N/A 14,254,000.00
Adjustments For Unrealised Foreign Exchange Losses Gains -332,000.00 N/A 639,000.00
Other Adjustments For Noncash Items 230,000.00 N/A -431,000.00
Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow 0.00 N/A -27,308,000.00
Other Adjustments To Reconcile Profit Loss -33,000.00 N/A 110,000.00
Income Taxes Paid Refund Classified As Operating Activities 65,000.00 N/A -45,000.00
Cash Flows From Used In Operating Activities -2,248,000.00 N/A -5,853,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 7,000.00 N/A 0.00
Cash Flows From Used In Investing Activities -5,016,000.00 N/A 0.00
Proceeds From Borrowings Classified As Financing Activities 9,858,000.00 N/A 3,713,000.00
Repayments Of Borrowings Classified As Financing Activities 917,000.00 N/A 0.00
Payments Of Lease Liabilities Classified As Financing Activities 215,000.00 N/A 0.00
Cash Flows From Used In Financing Activities 8,726,000.00 N/A 3,713,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 1,462,000.00 N/A -2,140,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents 46,000.00 N/A -46,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes 1,508,000.00 N/A -2,186,000.00
Cash and cash equivalents 2,215,000.00 707,000.00 29,000.00

Please note that some sums might not add up.

Filings & Publications

2021

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

PLAIRWY00017

LEI

259400MDMODKWHZ2EU17

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Warsaw Stock Exchange

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.